Publisher Correction: Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection (Nature Genetics, (2018), 50, 3, (381-389), 10.1038/s41588-018-0059-2);Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection

Nature Genetics

Volumn 50, Issue 3, 2018, Pages 381-389

  Pardiñas, Antonio F ^a   Holmans, Peter ^a   Pocklington, Andrew J ^a   Escott Price, Valentina ^a   Ripke, Stephan ^b,c   Carrera, Noa ^a   Legge, Sophie E ^a   Bishop, Sophie ^a   Cameron, Darren ^a   Hamshere, Marian L ^a   Han, Jun ^a   Hubbard, Leon ^a   Lynham, Amy ^a   Mantripragada, Kiran ^a   Rees, Elliott ^a   MacCabe, James H ^d   McCarroll, Steven A ^e   Baune, Bernhard T ^f   Breen, Gerome ^d,g   Byrne, Enda M ^h   Dannlowski, Udo ⁱ   Eley, Thalia C ^g   Hayward, Caroline ^j   Martin, Nicholas G ^h,k   McIntosh, Andrew M ^j   Plomin, Robert ^g   Porteous, David J ^j   Wray, Naomi R ^h   Caballero, Armando ^l   Geschwind, Daniel H ^m   Huckins, Laura M ⁿ   Ruderfer, Douglas M ⁿ   Santiago, Enrique ^o   Sklar, Pamela ⁿ   Stahl, Eli A ⁿ   Won, Hyejung ^m   Agerbo, Esben ^p,q   Als, Thomas D ^p,q   Andreassen, Ole A ^r,s   Bækvad Hansen, Marie ^p,t   Mortensen, Preben Bo ^p,q   Pedersen, Carsten Bøcker ^p,q   Børglum, Anders D ^p,q   Bybjerg Grauholm, Jonas ^p,t   Djurovic, Srdjan ^s,u   Durmishi, Naser ^v   Pedersen, Marianne Giørtz ^p,q   Golimbet, Vera ^w   Grove, Jakob ^p,q   Hougaard, David M ^p,t   Mattheisen, Manuel ^p,q   Molden, Espen ^x   Mors, Ole ^p,y   Nordentoft, Merete ^p,z   Pejovic Milovancevic, Milica ^aa   Sigurdsson, Engilbert ^ab   Silagadze, Teimuraz ^ac   Hansen, Christine Søholm ^p,t   Stefansson, Kari ^ad   Stefansson, Hreinn ^ad   Steinberg, Stacy ^ad   Tosato, Sarah ^ae   Werge, Thomas ^p,z,af   Harold, Denise ^a,aj   Sims, Rebecca ^a   Gerrish, Amy ^a   Chapman, Jade ^a   Abraham, Richard ^a   Hollingworth, Paul ^a   Pahwa, Jaspreet ^a   Denning, Nicola ^a   Thomas, Charlene ^a   Taylor, Sarah ^a   Powell, John ^d   Proitsi, Petroula ^d   Lupton, Michelle ^d   Lovestone, Simon ^d,ak   Passmore, Peter ^al   Craig, David ^al   McGuinness, Bernadette ^al   Johnston, Janet ^al   Todd, Stephen ^al   Maier, Wolfgang ^am   Jessen, Frank ^am   Heun, Reiner ^am   Schurmann, Britta ^am   Ramirez, Alfredo ^am   Becker, Tim ^an   Herold, Christine ^an   Lacour, André ^an   Drichel, Dmitriy ^an   Nothen, Markus ^am   Goate, Alison ^ao   Cruchaga, Carlos ^ao   Nowotny, Petra ^ao   Morris, John C ^ao   Mayo, Kevin ^ao   O'Donovan, Michael C ^a   Owen, Michael J ^a   Williams, Julie ^a   Achilla, Evanthia ^d   Barr, Cathy L ^ap   Böttger, Theresa Wimberly ^q   Cohen, Dan ^aq   Curran, Sarah ^d,ar   Dempster, Emma ^as   Dima, Danai ^g   Sabes Figuera, Ramon ^d   Flanagan, Robert J ^at   Frangou, Sophia ⁿ   Frank, Josef ^au   Gasse, Christiane ^q   Gaughran, Fiona ^d   Giegling, Ina ^ah   Hannon, Eilis ^as   Hartmann, Annette M ^ah   Heißerer, Barbara ^av   Helthuis, Marinka ^aw   Horsdal, Henriette Thisted ^q   Ingimarsson, Oddur ^ab   Jollie, Karel ^aw   Kennedy, James L ^ax   Köhler, Ole ^x   Konte, Bettina ^ah   Lang, Maren ^au   Lewis, Cathryn ^g   MacCaba, James ^d   Malhotra, Anil K ^ay   McCrone, Paul ^d   Meier, Sandra M ^q   Mill, Jonathan ^g,as   Pedersen, Carsten B ^p,q   Rietschel, Marcella ^au   Rujescu, Dan ^ah,ai   Schwalber, Ameli ^av   Sørensen, Holger J ^z   Spencer, Benjamin ^d   Støvring, Henrik ^q   Strohmaier, Jana ^au   Sullivan, Patrick ^az,ba   Vassos, Evangelos ^g   Verbelen, Moira ^g   Collier, David A ^g,ag   Kirov, George ^a   Walters, James T R ^a   more..

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^f UNIVERSITY OF ADELAIDE   (Australia)

^g MEDICAL RESEARCH COUNCIL   (United Kingdom)

^h UNIVERSITY OF QUEENSLAND   (Australia)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

^j UNIVERSITY OF EDINBURGH   (United Kingdom)

^k QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^l UNIVERSITY OF VIGO   (Spain)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^o DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^p The Lundbeck Foundation s Initiative for Integrative Psychiatric Research   (Denmark)

^q AARHUS UNIVERSITY   (Denmark)

^r UNIVERSITY OF OSLO   (Norway)

^s OSLO UNIVERSITY HOSPITAL   (Norway)

^t STATENS SERUM INSTITUT   (Denmark)

^u UNIVERSITY OF BERGEN   (Norway)

^v University Clinic of Psychiatry   (Macedonia)

^w MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^x DIAKONHJEMMET HOSPITAL   (Norway)

^y AARHUS UNIVERSITY HOSPITAL   (Denmark)

^z UNIVERSITY OF COPENHAGEN   (Denmark)

^aa UNIVERSITY OF BELGRADE   (Serbia)

^ab LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^ac TBILISI STATE MEDICAL UNIVERSITY   (Georgia)

^ad DECODE GENETICS   (Iceland)

^ae UNIVERSITY OF VERONA   (Italy)

^af Psychiatric Centre Sct Hans   (Denmark)

^ag ELI LILLY AND COMPANY   (United States)

^ah MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^ai UNIVERSITY OF MUNICH   (Germany)

^aj ST JAMES S HOSPITAL   (Ireland)

^ak UNIVERSITY OF OXFORD   (United Kingdom)

^al QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^am UNIVERSITY OF BONN   (Germany)

^an GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^ao WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ap UNIVERSITY HEALTH NETWORK   (Canada)

^aq Department of Severe Mental Illness   (Netherlands)

^ar UNIVERSITY OF SUSSEX   (United Kingdom)

^as UNIVERSITY OF EXETER MEDICAL SCHOOL   (United Kingdom)

^at KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^au MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^av Leyden Delta ^*  (Germany)

^aw Leyden Delta   (Netherlands)

^ax CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^ay ZUCKER HILLSIDE HOSPITAL   (United States)

^az UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^ba KAROLINSKA INSTITUTE   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; SEROTONIN 2C RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL;

ALLELE; ARTICLE; BACKGROUND SELECTION; BRAIN TISSUE; CHROMOSOME STRUCTURE; CONTROLLED STUDY; COPY NUMBER VARIATION; EXPRESSION QUANTITATIVE TRAIT LOCUS; GENE EXPRESSION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENETIC CORRELATION; GENETIC RISK; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HERITABILITY; HUMAN; INTROGRESSION; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; CASE CONTROL STUDY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC SELECTION; GENETICS; INHERITANCE; LETHAL GENE; META ANALYSIS;

ALLELES; CASE-CONTROL STUDIES; GENE FREQUENCY; GENES, LETHAL; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; INHERITANCE PATTERNS; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SELECTION, GENETIC;

EID: 85042546549     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/s41588-019-0450-7     Document Type: Erratum

References (105)

1. Owen, M. J., Sawa, A. &Mortensen, P. B. Schizophrenia. Lancet 388, 86-97 (2016).
2. Thornicroft, G. Physical health disparities and mental illness: the scandal of premature mortality. Br. J. Psychiatry 199, 441-442 (2011).
3. Olfson, M., Gerhard, T., Huang, C., Crystal, S. &Stroup, T. S. Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 72, 1172-1181 (2015).
4. Morgan, C. et al. Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. Psychol. Med. 44, 2713-2726 (2014).
5. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature 511, 421-427 (2014).
6. Singh, T. et al. Rare loss-of-function variants in SETD1A are associated with schizophrenia and developmental disorders. Nat. Neurosci. 19, 571-577 (2016).
7. Rees, E. et al. Analysis of copy number variations at 15 schizophreniaassociated loci. Br. J. Psychiatry 204, 108-114 (2014).
8. Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185-190 (2014).
9. Power, R. A. et al. Fecundity of patients with schizophrenia, autism, bipolar disorder, depression, anorexia nervosa, or substance abuse vs their unaffected siblings. JAMA Psychiatry 70, 22-30 (2013).
10. Huxley, J., Mayr, E., Osmond, H. &Hoffer, A. Schizophrenia as a genetic morphism. Nature 204, 220-221 (1964).
11. Shaner, A., Miller, G. &Mintz, J. Schizophrenia as one extreme of a sexually selected fitness indicator. Schizophr. Res. 70, 101-109 (2004).
12. Srinivasan, S. et al. Genetic markers of human evolution are enriched in schizophrenia. Biol. Psychiatry 80, 284-292 (2016).
13. Uher, R. The role of genetic variation in the causation of mental illness: An evolution-informed framework. Mol. Psychiatry 14, 1072-1082 (2009).
14. Ripke, S. et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 45, 1150-1159 (2013).
15. Shi, Y. et al. Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat. Genet. 43, 1224-1227 (2011).
16. Deciphering Developmental Disorders Study. Prevalence and architecture of de novo mutations in developmental disorders. Nature 542, 433-438 (2017).
17. Kosmicki, J. A. et al. Refining the role of de novo protein-truncating variants in neurodevelopmental disorders by using population reference samples. Nat. Genet. 49, 504-510 (2017).
18. Samocha, K. E. et al. A framework for the interpretation of de novo mutation in human disease. Nat. Genet. 46, 944-950 (2014).
19. Genovese, G. et al. Increased burden of ultra-rare protein-altering variants among 4,877 individuals with schizophrenia. Nat. Neurosci. 19, 1433-1441 (2016).
20. de Leeuw, C. A., Mooij, J. M., Heskes, T. &Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. 11, e1004219 (2015).
21. Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285-291 (2016).
22. Fagerberg, L. et al. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol. Cell. Proteomics 13, 397-406 (2014).
23. Smith, N. G. C. &Eyre-Walker, A. Human disease genes: patterns and predictions. Gene 318, 169-175 (2003).
24. Blekhman, R. et al. Natural selection on genes that underlie human disease susceptibility. Curr. Biol. 18, 883-889 (2008).
25. Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42, D1001-D1006 (2014).
26. Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228-1235 (2015).
27. Takata, A., Ionita-Laza, I., Gogos, J. A., Xu, B. &Karayiorgou, M. De novo synonymous mutations in regulatory elements contribute to the genetic etiology of autism and schizophrenia. Neuron 89, 940-947 (2016).
28. Huber, C. D., DeGiorgio, M., Hellmann, I. &Nielsen, R. Detecting recent selective sweeps while controlling for mutation rate and background selection. Mol. Ecol. 25, 142-156 (2016).
29. McVicker, G., Gordon, D., Davis, C. &Green, P. Widespread genomic signatures of natural selection in hominid evolution. PLoS Genet. 5, e1000471 (2009).
30. Pocklington, A. J. et al. Novel findings from CNVs implicate inhibitory and excitatory signaling complexes in schizophrenia. Neuron 86, 1203-1214 (2015).
31. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014).
32. Darnell, J. C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261 (2011).
33. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299 (2012).
34. Szatkiewicz, J. P. et al. Copy number variation in schizophrenia in Sweden. Mol. Psychiatry 19, 762-773 (2014).
35. Blake, J. A., Bult, C. J., Eppig, J. T., Kadin, J. A. &Richardson, J. E. The Mouse Genome Database: integration of and access to knowledge about the laboratory mouse. Nucleic Acids Res. 42, D810-D817 (2014).
36. Müller, C. S. et al. Quantitative proteomics of the Cav2 channel nanoenvironments in the mammalian brain. Proc. Natl. Acad. Sci. USA 107, 14950-14957 (2010).
37. Bécamel, C. et al. Synaptic multiprotein complexes associated with 5-HT2C receptors: A proteomic approach. EMBO J. 21, 2332-2342 (2002).
38. Liu, J. et al. Prediction of efficacy of vabicaserin, a 5-HT2C agonist, for the treatment of schizophrenia using a quantitative systems pharmacology model. CPT Pharmacometrics Syst. Pharmacol. 3, e111 (2014).
39. Benner, C. et al. FINEMAP: efficient variable selection using summary data from genome-wide association studies. Bioinformatics 32, 1493-1501 (2016).
40. Wang, K., Li, M. &Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164-e164 (2010).
41. Won, H. et al. Chromosome conformation elucidates regulatory relationships in developing human brain. Nature 538, 523-527 (2016).
42. Park, J. H. et al. SLC39A8 deficiency: A disorder of manganese transport and glycosylation. Am. J. Hum. Genet. 97, 894-903 (2015).
43. Zhu, Z. et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat. Genet. 48, 481-487 (2016).
44. Fromer, M. et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat. Neurosci. 19, 1442-1453 (2016).
45. Charlesworth, B. The effects of deleterious mutations on evolution at linked sites. Genetics 190, 5-22 (2012).
46. Charlesworth, B., Betancourt, A. J., Kaiser, V. B. &Gordo, I. Genetic recombination and molecular evolution. Cold Spring Harb. Symp. Quant. Biol. 74, 177-186 (2009).
47. Comeron, J. M., Williford, A. &Kliman, R. M. The Hill-Robertson effect: evolutionary consequences of weak selection and linkage in finite populations. Heredity 100, 19-31 (2008).
48. Charlesworth, B. Background selection 20 years on: the Wilhelmine E. Key 2012 Invitational Lecture. J. Hered. 104, 161-171 (2013).
49. North, T. L. &Beaumont, M. A. Complex trait architecture: the pleiotropic model revisited. Sci. Rep. 5, 9351 (2015).
50. Rockman, M. V., Skrovanek, S. S. &Kruglyak, L. Selection at linked sites shapes heritable phenotypic variation in C. elegans. Science 330, 372-376 (2010).
51. Vitti, J. J., Grossman, S. R. &Sabeti, P. C. Detecting natural selection in genomic data. Annu. Rev. Genet. 47, 97-120 (2013).
52. Stephan, W. Signatures of positive selection: from selective sweeps at individual loci to subtle allele frequency changes in polygenic adaptation. Mol. Ecol. 25, 79-88 (2016).
53. Field, Y. et al. Detection of human adaptation during the past 2000 years. Science 354, 760-764 (2016).
54. Key, F. M., Fu, Q., Romagné, F., Lachmann, M. &Andrés, A. M. Human adaptation and population differentiation in the light of ancient genomes. Nat. Commun. 7, 10775 (2016).
55. Harris, K. &Nielsen, R. The genetic cost of Neanderthal introgression. Genetics 203, 881-891 (2016).
56. Peloso, G. M. &Lunetta, K. L. Choice of population structure informative principal components for adjustment in a case-control study. BMC Genet. 12, 64 (2011).
57. Pirinen, M., Donnelly, P. &Spencer, C. C. A. Including known covariates can reduce power to detect genetic effects in case-control studies. Nat. Genet. 44, 848-851 (2012).
58. Bouaziz, M., Ambroise, C. &Guedj, M. Accounting for population stratification in practice: A comparison of the main strategies dedicated to genome-wide association studies. PLoS One 6, e28845 (2011).
59. Tucker, G., Price, A. L. &Berger, B. Improving the power of GWAS and avoiding confounding from population stratification with PC-Select. Genetics 197, 1045-1049 (2014).
60. Willer, C. J., Li, Y. &Abecasis, G. R. METAL: fast and efficient metaanalysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
61. Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291-295 (2015).
62. Perälä, J. et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch. Gen. Psychiatry 64, 19-28 (2007).
63. McGrath, J., Saha, S., Chant, D. &Welham, J. Schizophrenia: A concise overview of incidence, prevalence, and mortality. Epidemiol. Rev. 30, 67-76 (2008).
64. Bulik-Sullivan, B. et al. An atlas of genetic correlations across human diseases and traits. Nat. Genet. 47, 1236-1241 (2015).
65. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium. Genome-wide association study identifies five new schizophrenia loci. Nat. Genet. 43, 969-976 (2011).
66. Tansey, K. E. et al. Common alleles contribute to schizophrenia in CNV carriers. Mol. Psychiatry 21, 1085-1089 (2015).
67. Dudbridge, F. Polygenic epidemiology. Genet. Epidemiol. 40, 268-272 (2016).
68. Lee, S. H., Goddard, M. E., Wray, N. R. &Visscher, P. M. A better coefficient of determination for genetic profile analysis. Genet. Epidemiol. 36, 214-224 (2012).
69. Maston, G. A., Evans, S. K. &Green, M. R. Transcriptional regulatory elements in the human genome. Annu. Rev. Genomics Hum. Genet. 7, 29-59 (2006).
70. Network and Pathway Analysis Subgroup of Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat. Neurosci. 18, 199-209 (2015).
71. Cox, D. D. &Lee, J. S. Pointwise testing with functional data using the Westfall-Young randomization method. Biometrika 95, 621-634 (2008).
72. Batada, N. N., Hurst, L. D. &Tyers, M. Evolutionary and physiological importance of hub proteins. PLoS Comput. Biol. 2, e88 (2006).
73. Parikshak, N. N., Gandal, M. J. &Geschwind, D. H. Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders. Nat. Rev. Genet. 16, 441-458 (2015).
74. Pocklington, A. J., Cumiskey, M., Armstrong, J. D. &Grant, S. G. N. The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Mol. Syst. Biol. 2, 2006.0023 (2006).
75. Fernández, E. et al. Targeted tandem affinity purification of PSD-95 recovers core postsynaptic complexes and schizophrenia susceptibility proteins. Mol. Syst. Biol. 5, 269 (2009).
76. Kirov, G. et al. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol. Psychiatry 17, 142-153 (2012).
77. Pers, T. H. et al. Comprehensive analysis of schizophrenia-associated loci highlights ion channel pathways and biologically plausible candidate causal genes. Hum. Mol. Genet. 25, 1247-1254 (2016).
78. Gene Ontology Consortium. Gene Ontology Consortium: going forward. Nucleic Acids Res. 43, D1049-D1056 (2015).
79. Fabregat, A. et al. The Reactome Pathway Knowledgebase. Nucleic Acids Res. 44 (D1), D481-D487 (2016).
80. Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. &Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res 44 (D1), D457-D462 (2016).
81. Amberger, J. S., Bocchini, C. A., Schiettecatte, F., Scott, A. F. &Hamosh, A. OMIM.org: Online Mendelian Inheritance in Man (OMIM® ), an online catalog of human genes and genetic disorders. Nucleic Acids Res. 43, D789-D798 (2015).
82. de Leeuw, C. A., Neale, B. M., Heskes, T. &Posthuma, D. The statistical properties of gene-set analysis. Nat. Rev. Genet. 17, 353-364 (2016).
83. O'Leary, N. A. et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 44 (D1), D733-D745 (2016).
84. van Dongen, J. &Boomsma, D. I. The evolutionary paradox and the missing heritability of schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 162B, 122-136 (2013).
85. Xu, K., Schadt, E. E., Pollard, K. S., Roussos, P. &Dudley, J. T. Genomic and network patterns of schizophrenia genetic variation in human evolutionary accelerated regions. Mol. Biol. Evol. 32, 1148-1160 (2015).
86. Voight, B. F., Kudaravalli, S., Wen, X. &Pritchard, J. K. A map of recent positive selection in the human genome. PLoS Biol. 4, e72 (2006).
87. Sabeti, P. C. et al. Genome-wide detection and characterization of positive selection in human populations. Nature 449, 913-918 (2007).
88. Grossman, S. R. et al. Identifying recent adaptations in large-scale genomic data. Cell 152, 703-713 (2013).
89. Sankararaman, S. et al. The genomic landscape of Neanderthal ancestry in present-day humans. Nature 507, 354-357 (2014).
90. Sabeti, P. C. et al. Positive natural selection in the human lineage. Science 312, 1614-1620 (2006).
91. Ronen, R., Udpa, N., Halperin, E. &Bafna, V. Learning natural selection from the site frequency spectrum. Genetics 195, 181-193 (2013).
92. Nordborg, M., Charlesworth, B. &Charlesworth, D. The effect of recombination on background selection. Genet. Res. 67, 159-174 (1996).
93. Fu, W. &Akey, J. M. Selection and adaptation in the human genome. Annu. Rev. Genomics Hum. Genet. 14, 467-489 (2013).
94. Zhao, H. et al. CrossMap: A versatile tool for coordinate conversion between genome assemblies. Bioinformatics 30, 1006-1007 (2014).
95. Cunningham, F. et al. Ensembl 2015. Nucleic Acids Res. 43, D662-D669 (2015).
96. Altshuler, D. M. et al. Integrating common and rare genetic variation in diverse human populations. Nature 467, 52-58 (2010).
97. Maclean, C. A., Chue Hong, N. P. &Prendergast, J. G. hapbin: An efficient program for performing haplotype-based scans for positive selection in large genomic datasets. Mol. Biol. Evol. 32, 3027-3029 (2015).
98. Hussin, J. G. et al. Recombination affects accumulation of damaging and disease-associated mutations in human populations. Nat. Genet. 47, 400-404 (2015).
99. Ptok, U., Barkow, K. &Heun, R. Fertility and number of children in patients with Alzheimer's disease. Arch. Womens Ment. Health 5, 83-86 (2002).
100. Whitworth, K. W., Baird, D. D., Stene, L. C., Skjaerven, R. &Longnecker, M. P. Fecundability among women with type 1 and type 2 diabetes in the Norwegian Mother and Child Cohort Study. Diabetologia 54, 516-522 (2011).
101. Jokela, M. Birth-cohort effects in the association between personality and fertility. Psychol. Sci. 23, 835-841 (2012).
102. Zheng, J. et al. LD Hub: A centralized database and web interface to perform LD score regression that maximizes the potential of summary level GWAS data for SNP heritability and genetic correlation analysis. Bioinformatics 33, 272-279 (2017).
103. Lambert, J.-C. et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat. Genet. 45, 1452-1458 (2013).
104. Smith, D. J. et al. Genome-wide analysis of over 106 000 individuals identifies 9 neuroticism-associated loci. Mol. Psychiatry 21, 749-757 (2016).
105. Mahajan, A. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat. Genet. 46, 234-244 (2014).